Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Jul 28, 2026 | $2.29 | +26.5% | $2.89B | +18.5% | $2.48 |
| Q1 FY26ended Mar 31, 2026 | Apr 28, 2026 | $2.28 | +18.7% | $2.77B | +23.0% | $2.08 |
| Q4 FY25ended Dec 31, 2025 | — | $2.21 | +17.6% | $2.87B | +18.8% | — |
| Q3 FY25ended Sep 30, 2025 | — | $1.95 | +25.0% | $2.51B | +22.9% | — |
| Q2 FY25ended Jun 30, 2025 | — | $1.81 | +24.0% | $2.44B | +21.4% | — |
| Q1 FY25ended Mar 31, 2025 | — | $1.92 | +27.2% | $2.25B | +19.2% | — |
| Q4 FY24ended Dec 31, 2024 | — | $1.88 | +11.2% | $2.41B | +25.2% | — |
| Q3 FY24ended Sep 30, 2024 | — | $1.56 | +34.5% | $2.04B | +16.9% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Intuitive Surgical shares, not any token. As of Jul 28, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q2 FY24ended Jun 30, 2024 | — | $1.46 | — | $2.01B | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $1.51 | — | $1.89B | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $1.69 | — | $1.93B | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $1.16 | — | $1.74B | — | — |